Persistent Atrial Fibrillation
Cardiovascular·MeSH: Atrial Fibrillation
Prevalence
1200.0 / 100K
Incidence
100.0 / 100K/yr
2 drugs in development·2 companies·4 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| multaq | Sanofi (SNY) |
Preclinical(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Persistent Atrial Fibrillation?
BioSniper tracks 2 drugs in development for Persistent Atrial Fibrillation across 2 companies.
How many clinical trials target Persistent Atrial Fibrillation?
There are 4 clinical trials targeting Persistent Atrial Fibrillation tracked by BioSniper.
What is the prevalence of Persistent Atrial Fibrillation?
The estimated prevalence of Persistent Atrial Fibrillation is approximately 1200.0 per 100,000 population.
Deep-dive into Persistent Atrial Fibrillation
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis